Key highlights in amyloidosis at ASH 2023: diagnosis & novel immunotherapeutic agents being explored

Key highlights in amyloidosis at ASH 2023: diagnosis & novel immunotherapeutic agents being exploredПодробнее

Key highlights in amyloidosis at ASH 2023: diagnosis & novel immunotherapeutic agents being explored

ASH 2023 | AL amyloidosis highlightsПодробнее

ASH 2023 | AL amyloidosis highlights

Novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclaxПодробнее

Novel treatment approaches being explored in amyloidosis: immunotherapeutic agents & venetoclax

SCD highlights at ASH 2023: disease pathogenesis, ongoing clinical trials & novel gene therapiesПодробнее

SCD highlights at ASH 2023: disease pathogenesis, ongoing clinical trials & novel gene therapies

Psoriasis, What is psoriasis ? What is the cause of psoriasis?Подробнее

Psoriasis, What is psoriasis ? What is the cause of psoriasis?

Highlights in AL amyloidosis from ASH 2022: EMN22, EMN27 & predictors of hematologic CRПодробнее

Highlights in AL amyloidosis from ASH 2022: EMN22, EMN27 & predictors of hematologic CR

Thalassemia highlights at ASH 2023: novel therapies, trial updates & the value of precision medicineПодробнее

Thalassemia highlights at ASH 2023: novel therapies, trial updates & the value of precision medicine

Key highlights in amyloidosis from ASH 2020Подробнее

Key highlights in amyloidosis from ASH 2020

Key highlights in MPNs at ASH 2023: novel agents & combinations, ongoing clinical trials, and moreПодробнее

Key highlights in MPNs at ASH 2023: novel agents & combinations, ongoing clinical trials, and more

ASH 22 | AL amyloidosis highlightsПодробнее

ASH 22 | AL amyloidosis highlights

Key highlights from EBMT 2023Подробнее

Key highlights from EBMT 2023

Amyloid light chain (AL) amyloidosis | cardiac amyloidosis | amyloid deposits #medicalanimationПодробнее

Amyloid light chain (AL) amyloidosis | cardiac amyloidosis | amyloid deposits #medicalanimation

The current landscape of immunotherapy for AML: an update from ASH 2023Подробнее

The current landscape of immunotherapy for AML: an update from ASH 2023

Amyloidosis: diagnosis and stem cell transplantationПодробнее

Amyloidosis: diagnosis and stem cell transplantation

Highlights from the BSH amyloidosis sessionПодробнее

Highlights from the BSH amyloidosis session

Advancements in AML: an update from ASH 2023Подробнее

Advancements in AML: an update from ASH 2023

The current landscape of treatment for HR-MDS: an update from ASH 2023Подробнее

The current landscape of treatment for HR-MDS: an update from ASH 2023

Advances in the diagnosis of AL amyloidosis: AmyLite diagnostic assayПодробнее

Advances in the diagnosis of AL amyloidosis: AmyLite diagnostic assay

Updates in amyloidosis at ASH 2020Подробнее

Updates in amyloidosis at ASH 2020